Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Pediatric C. Difficile
NCT02636517Phase 1Enrolling by invitation
- Sponsor
- Judith Kelsen
- Start
- Dec 2015
- Primary completion
- Dec 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label trial of fecal microbiome transplant in Clostridioides difficile infection (CDI) (2 arms), sponsored by Judith Kelsen. Primary endpoint: Number of subjects with a recurrence of C. difficile (CDI) at 7 days. Started Dec 2015; status: enrolling by invitation.
02
Drugs
fecal microbiome transplant
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02636517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636517.